{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:22:57Z","timestamp":1793762577375,"version":"4.6.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41380-024-02789-x","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T02:02:22Z","timestamp":1728698542000},"page":"1817-1827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cannabidiol ameliorates cognitive decline in 5\u00d7FAD mouse model of\u00a0Alzheimer\u2019s disease through potentiating the function of extrasynaptic glycine receptors"],"prefix":"10.1038","volume":"30","author":[{"given":"Jin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1082-2783","authenticated-orcid":false,"given":"Chonglei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3498-8163","authenticated-orcid":false,"given":"Kai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-9072","authenticated-orcid":false,"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-3749","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guichang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"2789_CR1","doi-asserted-by":"crossref","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Primers. 2015;1:15056.","DOI":"10.1038\/nrdp.2015.56"},{"key":"2789_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0140-6736(21)01449-5","volume":"398","author":"P Scheltens","year":"2021","unstructured":"Scheltens P. Responding to responsive behaviour in Alzheimer\u2019s disease reply. Lancet. 2021;398:842\u2013842.","journal-title":"Lancet"},{"key":"2789_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"J Gaugler","year":"2022","unstructured":"Gaugler J, James B, Johnson T, Reimer J, Solis M, Weuve J, et al. 2022 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2022;18:700\u201389.","journal-title":"Alzheimers Dement"},{"key":"2789_CR4","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.neuron.2022.03.008","volume":"110","author":"JS Sadick","year":"2022","unstructured":"Sadick JS, O'Dea MR, Hasel P, Dykstra T, Faustin A, Liddelow SA. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer\u2019s disease. Neuron. 2022;110:1788\u2013+.","journal-title":"Neuron"},{"key":"2789_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-012-1038-9","volume":"124","author":"JL Crimins","year":"2012","unstructured":"Crimins JL, Rocher AB, Luebke JI. Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy. Acta Neuropathologica. 2012;124:777\u201395.","journal-title":"Acta Neuropathologica"},{"key":"2789_CR6","doi-asserted-by":"crossref","unstructured":"Anastacio HTD, Matosin N, Ooi L. Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 2022;12:257.","DOI":"10.1038\/s41398-022-02024-7"},{"key":"2789_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science. 2008;321:1686\u20139.","journal-title":"Science"},{"key":"2789_CR8","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/nn.4163","volume":"18","author":"MA Busche","year":"2015","unstructured":"Busche MA, Grienberger C, Keskin AD, Song B, Neumann U, Staufenbiel M, et al. Decreased amyloid-beta and increased neuronal hyperactivity by immunotherapy in Alzheimer\u2019s models. Nat Neurosci. 2015;18:1725\u20137.","journal-title":"Nat Neurosci"},{"key":"2789_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron. 2007;55:697\u2013711.","journal-title":"Neuron"},{"key":"2789_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65:404\u201311.","journal-title":"Neurology"},{"key":"2789_CR11","doi-asserted-by":"crossref","unstructured":"Gail Canter R, Huang WC, Choi H, Wang J, Ashley Watson L, Yao CG, et al. 3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice. Commun Biol. 2019;2:360.","DOI":"10.1038\/s42003-019-0599-8"},{"key":"2789_CR12","doi-asserted-by":"crossref","unstructured":"Aso E, Ferrer I. Cannabinoids for treatment of Alzheimer\u2019s disease: moving toward the clinic. Front Pharmacol. 2014;5:37.","DOI":"10.3389\/fphar.2014.00037"},{"key":"2789_CR13","doi-asserted-by":"crossref","unstructured":"Abate G, Uberti D, Tambaro S. Potential and Limits of Cannabinoids in Alzheimer\u2019s Disease Therapy. Biol Basel. 2021;10:542.","DOI":"10.3390\/biology10060542"},{"key":"2789_CR14","doi-asserted-by":"crossref","unstructured":"Xiong YY, Lim CS. Understanding the Modulatory Effects of Cannabidiol on Alzheimer\u2019s Disease. Brain Sci. 2021;11:1211.","DOI":"10.3390\/brainsci11091211"},{"key":"2789_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/d41586-023-01537-5","volume":"617","author":"S Reardon","year":"2023","unstructured":"Reardon S. Alzheimer\u2019s drug donanemab: what promising trial means for treatments. Nature. 2023;617:232\u20133.","journal-title":"Nature"},{"key":"2789_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-141014","volume":"43","author":"E Aso","year":"2015","unstructured":"Aso E, S\u00e1nchez-Pla A, Vegas-Lozano E, Maldonado R, Ferrer I. Cannabis-based medicine reduces multiple pathological processes in AbetaPP\/PS1 mice. J Alzheimers Dis. 2015;43:977\u201391.","journal-title":"J Alzheimers Dis"},{"key":"2789_CR17","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","volume":"79","author":"AM Mart\u00edn-Moreno","year":"2011","unstructured":"Mart\u00edn-Moreno AM, Reigada D, Ram\u00edrez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer\u2019s Disease. Mol Pharmacol. 2011;79:964\u201373.","journal-title":"Mol Pharmacol"},{"key":"2789_CR18","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3233\/JAD-140921","volume":"42","author":"D Cheng","year":"2014","unstructured":"Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer\u2019s Disease Transgenic Mice. J Alzheimers Dis. 2014;42:1383\u201396.","journal-title":"J Alzheimers Dis"},{"key":"2789_CR19","doi-asserted-by":"crossref","unstructured":"Hao FJ, Feng YQ. Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP\/PS1 Alzheimer\u2019s mice uncovered by RNA-seq. Life Sci. 2021;264:118624.","DOI":"10.1016\/j.lfs.2020.118624"},{"key":"2789_CR20","doi-asserted-by":"crossref","unstructured":"Defrancesco M, Hofer A. Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer\u2019s Dementia: A Clinical Case Report. Front Psychiatry, 2020;11:413.","DOI":"10.3389\/fpsyt.2020.00413"},{"key":"2789_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nchembio.552","volume":"7","author":"W Xiong","year":"2011","unstructured":"Xiong W, Cheng K, Cui T, Godlewski G, Rice KC, Xu Y, et al. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia. Nat Chem Biol. 2011;7:296\u2013303.","journal-title":"Nat Chem Biol"},{"key":"2789_CR22","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.20120242","volume":"209","author":"W Xiong","year":"2012","unstructured":"Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting alpha3 glycine receptors. J Exp Med. 2012;209:1121\u201334.","journal-title":"J Exp Med"},{"key":"2789_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nn.3615","volume":"17","author":"W Xiong","year":"2014","unstructured":"Xiong W, Chen SR, He L, Cheng K, Zhao YL, Chen H, et al. Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease. Nat Neurosci. 2014;17:232\u20139.","journal-title":"Nat Neurosci"},{"key":"2789_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1074\/jbc.RA119.011221","volume":"295","author":"G Zou","year":"2020","unstructured":"Zou G, Xia J, Han Q, Liu D, Xiong W. The synthetic cannabinoid dehydroxylcannabidiol restores the function of a major GABA(A) receptor isoform in a cell model of hyperekplexia. J Biol Chem. 2020;295:138\u201345.","journal-title":"J Biol Chem"},{"key":"2789_CR25","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1016\/j.celrep.2020.02.106","volume":"30","author":"G Zou","year":"2020","unstructured":"Zou G, Zuo X, Chen K, Ge Y, Wang X, Xu G, et al. Cannabinoids Rescue Cocaine-Induced Seizures by Restoring Brain Glycine Receptor Dysfunction. Cell Rep. 2020;30:4209\u2013+.","journal-title":"Cell Rep"},{"key":"2789_CR26","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s42255-022-00633-6","volume":"4","author":"G Zou","year":"2022","unstructured":"Zou G, Xia J, Luo H, Xiao D, Jin J, Miao C, et al. Combined alcohol and cannabinoid exposure leads to synergistic toxicity by affecting cerebellar Purkinje cells. Nat Metab. 2022;4:1138\u2013+.","journal-title":"Nat Metab"},{"key":"2789_CR27","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1016\/S0924-977X(10)70232-7","volume":"20","author":"R Pertwee","year":"2010","unstructured":"Pertwee R. Pharmacological actions of cannabinoids. Eur Neuropsychopharmacol. 2010;20:S205.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2789_CR28","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1124\/mol.105.019174","volume":"69","author":"N Hejazi","year":"2006","unstructured":"Hejazi N, Zhou C, Oz M, Sun H, Ye JH, Zhang L. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. Mol Pharm. 2006;69:991\u20137.","journal-title":"Mol Pharm"},{"key":"2789_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1476-5381.2011.01471.x","volume":"164","author":"GE Yevenes","year":"2011","unstructured":"Yevenes GE, Zeilhofer HU. Allosteric modulation of glycine receptors. Br J Pharmacol. 2011;164:224\u201336.","journal-title":"Br J Pharmacol"},{"key":"2789_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2004.06.007","volume":"47","author":"LG Aguayo","year":"2004","unstructured":"Aguayo LG, van Zundert B, Tapia JC, Carrasco MA, Alvarez FJ. Changes on the properties of glycine receptors during neuronal development. Brain Res Rev. 2004;47:33\u201345.","journal-title":"Brain Res Rev"},{"key":"2789_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1152\/physrev.00043.2010","volume":"92","author":"HU Zeilhofer","year":"2012","unstructured":"Zeilhofer HU, Wildner H, Yevenes GE. Fast Synaptic Inhibition in Spinal Sensory Processing and Pain Control. Physiological Rev. 2012;92:193\u2013235.","journal-title":"Physiological Rev"},{"key":"2789_CR32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1152\/physrev.00042.2003","volume":"84","author":"JW Lynch","year":"2004","unstructured":"Lynch JW. Molecular structure and function of the glycine receptor chloride channel. Physiol Rev. 2004;84:1051\u201395.","journal-title":"Physiol Rev"},{"key":"2789_CR33","doi-asserted-by":"publisher","first-page":"E7179","DOI":"10.1073\/pnas.1703839114","volume":"114","author":"LM McCracken","year":"2017","unstructured":"McCracken LM, Lowes DC, Salling MC, Carreau-Vollmer C, Odean NN, Blednov YA, et al. Glycine receptor alpha3 and alpha2 subunits mediate tonic and exogenous agonist-induced currents in forebrain. Proc Natl Acad Sci USA. 2017;114:E7179\u201386.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2789_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fphar.2019.00309","volume":"10","author":"T Aitta-Aho","year":"2019","unstructured":"Aitta-Aho T, Maksimovic M, Dahl K, Sprengel R, Korpi ER. Attenuation of Novelty-Induced Hyperactivity of Gria1-\/- Mice by Cannabidiol and Hippocampal Inhibitory Chemogenetics. Front Pharmacol. 2019;10:309.","journal-title":"Front Pharmacol"},{"key":"2789_CR35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.cell.2017.07.021","volume":"170","author":"LN Driscoll","year":"2017","unstructured":"Driscoll LN, Pettit NL, Minderer M, Chettih SN, Harvey CD. Dynamic Reorganization of Neuronal Activity Patterns in Parietal Cortex. Cell. 2017;170:986\u2013+.","journal-title":"Cell"},{"key":"2789_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tetlet.2012.10.080","volume":"54","author":"SM Wilkinson","year":"2013","unstructured":"Wilkinson SM, Price J, Kassiou M. Improved accessibility to the desoxy analogues of Delta(9)-tetrahydrocannabinol and cannabidiol. Tetrahedron Lett. 2013;54:52\u201354.","journal-title":"Tetrahedron Lett"},{"key":"2789_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3233\/JAD-2012-120151","volume":"31","author":"R Zhang","year":"2012","unstructured":"Zhang R, Xue G, Wang S, Zhang L, Shi C, Xie X. Novel Object Recognition as a Facile Behavior Test for Evaluating Drug Effects in A beta PP\/PS1 Alzheimer\u2019s Disease Mouse Model. J Alzheimers Dis. 2012;31:801\u201312.","journal-title":"J Alzheimers Dis"},{"key":"2789_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01352-4","volume":"11","author":"M Rocha","year":"2021","unstructured":"Rocha M, Wang D, Avila-Quintero V, Bloch MH, Kaffman A. Deficits in hippocampal-dependent memory across different rodent models of early life stress: systematic review and meta-analysis. Transl Psychiatry. 2021;11:231.","journal-title":"Transl Psychiatry"},{"key":"2789_CR39","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, et al. The Amyloid-beta Pathway in Alzheimer\u2019s Disease. Mol Psychiatry. 2021;26:5481\u2013503.","journal-title":"Mol Psychiatry"},{"key":"2789_CR40","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran E, De Strooper B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat Rev Drug Discov. 2022;21:306\u201318.","journal-title":"Nat Rev Drug Discov"},{"key":"2789_CR41","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1523\/JNEUROSCI.2531-15.2016","volume":"36","author":"P Yuan","year":"2016","unstructured":"Yuan P, Grutzendler J. Attenuation of beta-Amyloid Deposition and Neurotoxicity by Chemogenetic Modulation of Neural Activity. J Neurosci. 2016;36:632\u201341.","journal-title":"J Neurosci"},{"key":"2789_CR42","doi-asserted-by":"publisher","first-page":"17091","DOI":"10.1523\/JNEUROSCI.4403-10.2010","volume":"30","author":"Z Liu","year":"2010","unstructured":"Liu Z, Condello C, Schain A, Harb R, Grutzendler J. CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-beta Phagocytosis. J Neurosci. 2010;30:17091\u2013101.","journal-title":"J Neurosci"},{"key":"2789_CR43","doi-asserted-by":"crossref","unstructured":"Condello C, Schain A, Grutzendler J. Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition. Sci Rep. 2011;1:19.","DOI":"10.1038\/srep00019"},{"key":"2789_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41586-022-05491-6","volume":"612","author":"P Yuan","year":"2022","unstructured":"Yuan P, Zhang M, Tong L, Morse TM, McDougal RA, Ding H, et al. PLD3 affects axonal spheroids and network defects in Alzheimer\u2019s disease. Nature. 2022;612:328\u2013+.","journal-title":"Nature"},{"key":"2789_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuron.2022.10.021","volume":"111","author":"J Hu","year":"2023","unstructured":"Hu J, Chen Q, Zhu H, Hou L, Liu W, Yang Q, et al. Microglial Piezo1 senses AD fibril stiffness to restrict Alzheimer\u2019s disease. Neuron. 2023;111:15\u2013+.","journal-title":"Neuron"},{"key":"2789_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5159","volume":"5","author":"Z Wu","year":"2014","unstructured":"Wu Z, Guo Z, Gearing M, Chen G. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer\u2019s [corrected] disease model. Nat Commun. 2014;5:4159.","journal-title":"Nat Commun"},{"key":"2789_CR47","doi-asserted-by":"publisher","first-page":"114511","DOI":"10.1016\/j.biopha.2023.114511","volume":"161","author":"E Cho","year":"2023","unstructured":"Cho E, Jeon SJ, Jeon J, Yi JH, Kwon H, Kwon HJ, et al. Phyllodulcin improves hippocampal long-term potentiation in 5XFAD mice. Biomed Pharmacother. 2023;161:114511.","journal-title":"Biomed Pharmacother"},{"key":"2789_CR48","doi-asserted-by":"publisher","first-page":"112763","DOI":"10.1016\/j.biopha.2022.112763","volume":"148","author":"E Cho","year":"2022","unstructured":"Cho E, Youn K, Kwon H, Jeon J, Cho WS, Park SJ, et al. Eugenitol ameliorates memory impairments in 5XFAD mice by reducing A\u03b2 plaques and neuroinflammation. Biomed Pharmacother. 2022;148:112763.","journal-title":"Biomed Pharmacother"},{"key":"2789_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45509-0","volume":"9","author":"M Wang","year":"2019","unstructured":"Wang M, Jo J, Song J. Adiponectin improves long-term potentiation in the 5XFAD mouse brain. Sci Rep. 2019;9:8918.","journal-title":"Sci Rep"},{"key":"2789_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pneurobio.2010.04.008","volume":"91","author":"TL Xu","year":"2010","unstructured":"Xu TL, Gong N. Glycine and glycine receptor signaling in hippocampal neurons: Diversity, function and regulation. Prog Neurobiol. 2010;91:349\u201361.","journal-title":"Prog Neurobiol"},{"key":"2789_CR51","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","volume":"187","author":"Y Wei","year":"2024","unstructured":"Wei Y, Li R, Meng Y, Hu T, Zhao J, Gao Y, et al. Article Transport mechanism and pharmacology of the human GlyT1. Cell. 2024;187:1719\u20131732.e14.","journal-title":"Cell"},{"key":"2789_CR52","doi-asserted-by":"crossref","first-page":"12979","DOI":"10.1523\/JNEUROSCI.3366-12.2012","volume":"32","author":"IA Khasabova","year":"2012","unstructured":"Khasabova IA, Xiong Y, Coicou LG, Piomelli D, Seybold V. A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors (April, pg 5200, 2012). J Neurosci. 2012;32:12979\u201312979.","journal-title":"J Neurosci"},{"key":"2789_CR53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuropharm.2018.01.041","volume":"133","author":"J Lu","year":"2018","unstructured":"Lu J, Fan S, Zou G, Hou Y, Pan T, Guo W, et al. Involvement of glycine receptor alpha1 subunits in cannabinoid-induced analgesia. Neuropharmacology. 2018;133:224\u201332.","journal-title":"Neuropharmacology"},{"key":"2789_CR54","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1021\/jm501873p","volume":"58","author":"MM Wells","year":"2015","unstructured":"Wells MM, Tillman TS, Mowrey DD, Sun T, Xu Y, Tang P. Ensemble-based virtual screening for cannabinoid-like potentiators of the human glycine receptor alpha1 for the treatment of pain. J Med Chem. 2015;58:2958\u201366.","journal-title":"J Med Chem"},{"key":"2789_CR55","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nprot.2016.021","volume":"11","author":"SL Resendez","year":"2016","unstructured":"Resendez SL, Jennings JH, Ung RL, Namboodiri VM, Zhou ZC, Otis JM, et al. Visualization of cortical, subcortical and deep brain neural circuit dynamics during naturalistic mammalian behavior with head-mounted microscopes and chronically implanted lenses. Nat Protoc. 2016;11:566\u201397.","journal-title":"Nat Protoc"},{"key":"2789_CR56","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.3390\/ijms232213954","volume":"23","author":"E Passeri","year":"2022","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, et al. Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations. Int J Mol Sci. 2022;23:13954.","journal-title":"Int J Mol Sci"},{"key":"2789_CR57","doi-asserted-by":"publisher","first-page":"105345","DOI":"10.1016\/j.nbd.2021.105345","volume":"154","author":"N Jiang","year":"2021","unstructured":"Jiang N, Cupolillo D, Grosjean N, Muller E, Deforges S, Mulle C, et al. Impaired plasticity of intrinsic excitability in the alters spike transfer in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2021;154:105345.","journal-title":"Neurobiol Dis"},{"key":"2789_CR58","doi-asserted-by":"crossref","unstructured":"Alcantara-Gonzalez D, Chartampila E, Criscuolo C, Scharfman HE. Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of Alzheimer\u2019s disease neuropathology and atypical effects of the cholinergic antagonist atropine. Neurobiol Dis. 2021;152:105274.","DOI":"10.1016\/j.nbd.2021.105274"},{"key":"2789_CR59","doi-asserted-by":"publisher","first-page":"103318","DOI":"10.1016\/j.nicl.2023.103318","volume":"37","author":"NC Shih","year":"2023","unstructured":"Shih NC, Kurniawan ND, Cabeen RP, Korobkova L, Wong E, Chui HC, et al. Microstructural mapping of dentate gyrus pathology in Alzheimer?s disease: A 16.4 Tesla MRI study. Neuroimage Clin. 2023;37:103318.","journal-title":"Neuroimage Clin"},{"key":"2789_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01499-1","volume":"10","author":"MO Mol","year":"2022","unstructured":"Mol MO, Miedema SSM, Melhem S, Li KW, Koopmans F, Seelaar H, et al. Proteomics of the dentate gyrus reveals semantic dementia specific molecular pathology. Acta Neuropathologica Commun. 2022;10:190.","journal-title":"Acta Neuropathologica Commun"},{"key":"2789_CR61","doi-asserted-by":"publisher","first-page":"e0119910","DOI":"10.1371\/journal.pone.0119910","volume":"10","author":"C Bezzina","year":"2015","unstructured":"Bezzina C, Verret L, Juan C, Remaud J, Halley H, Rampon C, et al. Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer\u2019s Disease. Plos One. 2015;10:e0119910.","journal-title":"Plos One"},{"key":"2789_CR62","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1073\/pnas.1133381100","volume":"100","author":"JJ Palop","year":"2003","unstructured":"Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J, et al. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer\u2019s disease-related cognitive deficits. Proc Natl Acad Sci USA. 2003;100:9572\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2789_CR63","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1523\/JNEUROSCI.20-05-01831.2000","volume":"20","author":"UV N\u00e4gerl","year":"2000","unstructured":"N\u00e4gerl UV, Mody I, Jeub M, Lie AA, Elger CE, Beck H. Surviving granule cells of the sclerotic human hippocampus have reduced Ca influx because of a loss of calbindin-D in temporal lobe epilepsy. J Neurosci. 2000;20:1831\u20136.","journal-title":"J Neurosci"},{"key":"2789_CR64","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1528-1167.2006.00554.x","volume":"47","author":"JC Amatniek","year":"2006","unstructured":"Amatniek JC, Hauser WA, DelCastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incidence and predictors of seizures in patients with Alzheimer\u2019s disease. Epilepsia. 2006;47:867\u201372.","journal-title":"Epilepsia"},{"key":"2789_CR65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.celrep.2019.12.030","volume":"30","author":"JE Hanson","year":"2020","unstructured":"Hanson JE, Ma K, Elstrott J, Weber M, Saillet S, Khan AS, et al. GluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer\u2019s Disease Models. Cell Rep. 2020;30:381\u2013+.","journal-title":"Cell Rep"},{"key":"2789_CR66","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/jama.2018.11914","volume":"320","author":"R Rubin","year":"2018","unstructured":"Rubin R. The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next. J Am Med Assoc. 2018;320:1227\u20139.","journal-title":"J Am Med Assoc"},{"key":"2789_CR67","doi-asserted-by":"crossref","unstructured":"Killestein J. Cannabinoids in the Treatment of Epilepsy. N Engl J Med. 2016;374:94\u20135.","DOI":"10.1056\/NEJMc1512758"},{"key":"2789_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","volume":"238","author":"SC Britch","year":"2021","unstructured":"Britch SC, Babalonis S, Walsh SL. Cannabidiol: pharmacology and therapeutic targets. Psychopharmacology. 2021;238:9\u201328.","journal-title":"Psychopharmacology"},{"key":"2789_CR69","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/cdd.2014.75","volume":"21","author":"A Avila","year":"2014","unstructured":"Avila A, Vidal PM, Tielens S, Morelli G, Laguesse S, Harvey RJ, et al. Glycine receptors control the generation of projection neurons in the developing cerebral cortex. Cell Death Differ. 2014;21:1696\u2013708.","journal-title":"Cell Death Differ"},{"key":"2789_CR70","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/dneu.22549","volume":"77","author":"MS Lin","year":"2017","unstructured":"Lin MS, Xiong WC, Li SJ, Gong Z, Cao X, Kuang XJ, et al. \u03b12-glycine receptors modulate adult hippocampal neurogenesis and spatial memory. Dev Neurobiol. 2017;77:1430\u201341.","journal-title":"Dev Neurobiol"},{"key":"2789_CR71","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.20120242","volume":"209","author":"W Xiong","year":"2012","unstructured":"Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, et al. Cannabinoids suppress inflammatory and neuropathic pain by targeting \u03b13 glycine receptors. J Exp Med. 2012;209:1121\u201334.","journal-title":"J Exp Med"},{"key":"2789_CR72","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1126\/science.1094925","volume":"304","author":"RJ Harvey","year":"2004","unstructured":"Harvey RJ, Depner UB, W\u00e4ssle H, Ahmadi S, Heindl C, Reinold H, et al. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization. Science. 2004;304:884\u20137.","journal-title":"Science"},{"key":"2789_CR73","doi-asserted-by":"publisher","first-page":"E7179","DOI":"10.1073\/pnas.1703839114","volume":"114","author":"LM McCracken","year":"2017","unstructured":"McCracken LM, Lowes DC, Salling MC, Carreau-Vollmer C, Odean NN, Blednov YA, et al. Glycine receptor \u03b13 and \u03b12 subunits mediate tonic and exogenous agonist-induced currents in forebrain. Proc Natl Acad Sci USA. 2017;114:E7179\u2013e7186.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2789_CR74","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.3390\/ijms23105367","volume":"23","author":"S Yang","year":"2022","unstructured":"Yang S, Du Y, Zhao X, Tang Q, Su W, Hu Y, et al. Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation. Int J Mol Sci. 2022;23:5367.","journal-title":"Int J Mol Sci"},{"key":"2789_CR75","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","volume":"35","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Titeler M, McKenney JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 1984;35:2505\u201311.","journal-title":"Life Sci"},{"key":"2789_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonz\u00e1lez-Maeso","year":"2007","unstructured":"Gonz\u00e1lez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron. 2007;53:439\u201352.","journal-title":"Neuron"},{"key":"2789_CR77","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3233\/JAD-191242","volume":"74","author":"G Watt","year":"2020","unstructured":"Watt G, Shang K, Zieba J, Olaya J, Li H, Garner B, et al. Chronic Treatment with 50\u200amg\/kg Cannabidiol Improves Cognition and Moderately Reduces A\u03b240 Levels in 12-Month-Old Male A\u03b2PPswe\/PS1\u0394E9 Transgenic Mice. J Alzheimers Dis. 2020;74:937\u201350.","journal-title":"J Alzheimers Dis"},{"key":"2789_CR78","doi-asserted-by":"publisher","first-page":"587604","DOI":"10.3389\/fphar.2020.587604","volume":"11","author":"M Coles","year":"2020","unstructured":"Coles M, Watt G, Kreilaus F, Karl T. Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP (Swe) \/PS1\u0394E9 Transgenic Female Mice. Front Pharm. 2020;11:587604.","journal-title":"Front Pharm"},{"key":"2789_CR79","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.12944","volume":"172","author":"JM McPartland","year":"2015","unstructured":"McPartland JM, Duncan M, Di Marzo V, Pertwee RG. Are cannabidiol and \u0394(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharm. 2015;172:737\u201353.","journal-title":"Br J Pharm"},{"key":"2789_CR80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00213-018-5127-x","volume":"236","author":"SF Lisboa","year":"2019","unstructured":"Lisboa SF, Vila-Verde C, Rosa J, Uliana DL, Stern C, Bertoglio LJ, et al. Tempering aversive\/traumatic memories with cannabinoids: a review of evidence from animal and human studies. Psychopharmacology. 2019;236:201\u201326.","journal-title":"Psychopharmacology"},{"key":"2789_CR81","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/jnc.14345","volume":"146","author":"B Calvo\u2010Flores Guzm\u00e1n","year":"2018","unstructured":"Calvo\u2010Flores Guzm\u00e1n B, Vinnakota C, Govindpani K, Waldvogel HJ, Faull RLM, Kwakowsky A. The GABAergic system as a therapeutic target for Alzheimer\u2019s disease. J Neurochem. 2018;146:649\u201369.","journal-title":"J Neurochem"},{"key":"2789_CR82","doi-asserted-by":"crossref","unstructured":"Carello-Collar G, Bellaver B, Ferreira PCL, Ferrari-Souza JP, Ramos VG, Therriault J, et al. The GABAergic system in Alzheimer\u2019s disease: a systematic review with meta-analysis. Mol Psychiatry. 2023;28:5025\u201336.","DOI":"10.1038\/s41380-023-02140-w"},{"key":"2789_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrn2370","volume":"9","author":"TC Jacob","year":"2008","unstructured":"Jacob TC, Moss SJ, Jurd R. GABA receptor trafficking and its role in the dynamic modulation of neuronal inhibition. Nat Rev Neurosci. 2008;9:331\u201343.","journal-title":"Nat Rev Neurosci"},{"key":"2789_CR84","doi-asserted-by":"publisher","first-page":"763868","DOI":"10.3389\/fnmol.2021.763868","volume":"14","author":"B Mu\u00f1oz","year":"2021","unstructured":"Mu\u00f1oz B, Mariqueo T, Murath P, Peters C, Yevenes GE, Moraga-Cid G, et al. Modulatory Actions of the Glycine Receptor beta Subunit on the Positive Allosteric Modulation of Ethanol in alpha 2 Containing Receptors. Front Mol Neurosci. 2021;14:763868.","journal-title":"Front Mol Neurosci"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02789-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02789-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02789-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:03:26Z","timestamp":1789113806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02789-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2789"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02789-x","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods in this study were performed in accordance with relevant guidelines and regulations. Ethical approval was obtained from the Institutional Review Board of Shandong First Medical University, with reference number W202406120618. Informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}